“We are partnered with Star Scientific, which will sell this compound as a dietary supplement.”
Dr. Michael Mullan
For 25 years, Dr. Michael Mullan has been a pioneer in Alzheimer’s research. He is also the director of the nonprofit Roskamp Institute, devoted to finding causes and cures for neuropsychiatric and neurodegenerative disorders and addictions. More recently, he’s the CEO of Archer Pharmaceuticals, Inc., a for-profit company built on Roskamp research. One of Archer’s products, Nilvadipine, an Alzheimer’s drug developed at Roskamp, has just received $8.4 million for a Phase III clinical trial—a significant achievement. The drug may act on the cause and not just the symptoms of Alzheimer’s. And this fall, Archer will help launch a new anti-inflammatory compound called ANATABLOC that could help in a range of diseases, including Alzheimer’s. “We are partnered with Star Scientific, which will sell this compound as a dietary supplement,” says Mullan, 54.
Read the full article at Biz(941)- http://www.biz941.com/ARTICLES/Current-Issue/People-to-Watch.aspx
I’m using 1 pill X 3 per day. The arthritis has gone from my hand entirely after years of pain and disability. And this after only just over 2 weeks of treatment. My wife is also using Anatabloc and after the same length of time, her chronic sciatic problem has almost disappeared after years of suffering. I don’t believe in miracles but I do believe in Anatabloc.
That’s awesome Tom! If you’re on Facebook, be sure to share your story on the Anatabloc wall!
Additionally, the dietary supplement assists avert difficulties and sleeplessness which might occur during nicotine withdrawal durations.
Hello, i’m Preston Halliday and I need to say that ” From Alzheimer’s breakthroughs to aquaculture advances, these 20 dynamos are changing our world. | Anatablocâ„¢ ” is literally a reliable piece of writing.